Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February
WILMINGTON, Del. -- January 24, 2013
Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its
fourth quarter/year-end 2012 financial results conference call for 8:30 a.m.
ET on Thursday, February 14, 2013. The schedules for the press release and
conference call are as follows:
-- Q4 & YE 2012 Press Release: February 14, 2013 at 7:00 a.m. ET
-- Q4 & YE 2012 Conference Call: February 14, 2013 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 407848
If you are unable to participate, a replay of the conference call will be
available for thirty days. The replay dial-in number for the U.S. is
877-660-6853 and dial-in number for international callers is 201-612-7415. To
access the replay you will need the conference ID number 407848.
The conference call will also be webcast live and can be accessed at
www.incyte.com under Investor Relations, Events and Webcasts.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company
focused on the discovery, development and commercialization of proprietary
small molecule drugs for oncology and inflammation. For additional information
on Incyte, please visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
Press spacebar to pause and continue. Press esc to stop.